Government to establish pricing criteria for efficacy-improved drugs

Published: 2007-10-31 06:57:00

Updated: 2007-10-31 06:57:00

When an efficacy-improved drug gets listed for insurance coverage, the corresponding drug price will be determined in the same scope of the original drug whose patent was expired, the Ministry of Health and Welfare said recently.

The efficacy-improved drug refers to a drug whose chemical struc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK